| 產(chǎn)品編號 | D51526 |
| 英文名稱 | Dactinomycin |
| 中文名稱 | |
| 別 名 | DNA修復(fù)抑制劑和autophagy激活劑 |
| 克 隆 號 | |
| CAS | 50-76-0 |
| 理論分子量 | 1255.42 kDa |
| 檢測分子量 | |
| 性 狀 | Lyophilized |
| 保存條件 | Store in dry, dark place for one year. |
| 注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 |
Dactinomycin (also known generically as Actinomycin D) is the most significant member of actinomycines, which are a class of polypeptide antibiotics isolated from soil bacteria of the genus Streptomyces. As one of the older chemotherapy drugs, it has been used for many years. Actinomycin D was the first antibiotic shown to have anti-cancer activity. It was first isolated by Selman Waksman and his co-worker H. B. Woodruff in 1940. It was approved by the US FDA on December 10, 1964 and launched by Merck Sharp and Dohme under the trade name Cosmegen. * 本產(chǎn)品為：Actinomycin D solution(10mM in DMSO)。 CAS：50-76-0 分子式：C62H86N12O16 分子量：1255.44 MDL：MFCD00005033 純度：＞98 % 靶點：RNA polymerase |
